Clinical trial
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
NCT06143956
Study timeline
Study start (actual)2023-11-17Date precision: day
Registry last updated2026-10-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityunresolved
Overweightunresolved
Interventions
LY3305677DRUG
LY3841136DRUG
TirzepatideDRUG · verified · RxNorm: tirzepatide
LY3549492DRUG
LY3532226DRUG
PlaceboDRUG
PlaceboDRUG
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Buenos AiresArgentina6ChicagoIllinois, United States2DallasTexas, United States2San AntonioTexas, United States2HoustonTexas, United States1MiamiFlorida, United States1NashvilleTennessee, United States1CincinnatiOhio, United States1PhoenixArizona, United States1OrlandoFlorida, United States1AustinTexas, United States1RochesterNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06143956 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.